{"transactions":[{"id":1479338,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T18:00:05.000Z","date":"2024-06-13","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 109,640 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":83510,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001415889-24-016993","document":"form4-06142024_060601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924016993/form4-06142024_060601.xml","form_type":"4"}},{"id":1479337,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-14T18:00:05.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":24.5,"value":147000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":5602,"source":{"system":"sec-edgar","filing":"0001415889-24-016993","document":"form4-06142024_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924016993/form4-06142024_060601.xml","form_type":"4"}},{"id":1479336,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-14T18:00:05.000Z","date":"2024-06-13","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":2.14,"value":12840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":11602,"source":{"system":"sec-edgar","filing":"0001415889-24-016993","document":"form4-06142024_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924016993/form4-06142024_060601.xml","form_type":"4"}},{"id":1511772,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-17T19:10:16.000Z","date":"2024-05-17","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":11324,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001415889-24-013630","document":"form4-05172024_070505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924013630/form4-05172024_070505.xml","form_type":"4"}},{"id":1511771,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-17T19:10:16.000Z","date":"2024-05-17","kind":"sale","planned":true,"acquired":false,"shares":86,"price":21.86,"value":1879.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":5602,"source":{"system":"sec-edgar","filing":"0001415889-24-013630","document":"form4-05172024_070505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924013630/form4-05172024_070505.xml","form_type":"4"}},{"id":1511770,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-17T19:10:16.000Z","date":"2024-05-17","kind":"sale","planned":true,"acquired":false,"shares":3914,"price":21.0658,"value":82451.5412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.605 to $21.50, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":5688,"source":{"system":"sec-edgar","filing":"0001415889-24-013630","document":"form4-05172024_070505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924013630/form4-05172024_070505.xml","form_type":"4"}},{"id":1511769,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-17T19:10:16.000Z","date":"2024-05-17","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":2.14,"value":8560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,351 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b3(d)."}],"balance_after":9602,"source":{"system":"sec-edgar","filing":"0001415889-24-013630","document":"form4-05172024_070505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924013630/form4-05172024_070505.xml","form_type":"4"}},{"id":1538503,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-19T18:00:15.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":false,"shares":3497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":539,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":3497},"source":{"system":"sec-edgar","filing":"0001415889-24-011251","document":"form4-04192024_060404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924011251/form4-04192024_060404.xml","form_type":"4"}},{"id":1538502,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-19T18:00:15.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":false,"shares":503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":2511,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":503},"source":{"system":"sec-edgar","filing":"0001415889-24-011251","document":"form4-04192024_060404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924011251/form4-04192024_060404.xml","form_type":"4"}},{"id":1538501,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-19T18:00:15.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":311,"price":23.3277,"value":7254.9147,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.12 to $23.97, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-24-011251","document":"form4-04192024_060404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924011251/form4-04192024_060404.xml","form_type":"4"}},{"id":1538500,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-19T18:00:15.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":3689,"price":22.3006,"value":82266.9134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.08 to $22.80, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3562,"source":{"system":"sec-edgar","filing":"0001415889-24-011251","document":"form4-04192024_060404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924011251/form4-04192024_060404.xml","form_type":"4"}},{"id":1538499,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-19T18:00:15.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":1.74,"value":6960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":7251,"source":{"system":"sec-edgar","filing":"0001415889-24-011251","document":"form4-04192024_060404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924011251/form4-04192024_060404.xml","form_type":"4"}},{"id":1556545,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-01T18:00:19.000Z","date":"2024-03-28","kind":"exercise","planned":true,"acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 109,640 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":89510,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001415889-24-009596","document":"form4-04012024_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924009596/form4-04012024_060401.xml","form_type":"4"}},{"id":1556544,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-01T18:00:19.000Z","date":"2024-03-28","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":29.5,"value":265500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-24-009596","document":"form4-04012024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924009596/form4-04012024_060401.xml","form_type":"4"}},{"id":1556543,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-01T18:00:19.000Z","date":"2024-03-28","kind":"exercise","planned":true,"acquired":true,"shares":9000,"price":2.14,"value":19260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":12251,"source":{"system":"sec-edgar","filing":"0001415889-24-009596","document":"form4-04012024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924009596/form4-04012024_060401.xml","form_type":"4"}},{"id":1566171,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-20T18:00:25.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 109,640 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":98510,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-008771","document":"form4-03202024_060312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924008771/form4-03202024_060312.xml","form_type":"4"}},{"id":1566170,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-20T18:00:25.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":4036,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001415889-24-008771","document":"form4-03202024_060312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924008771/form4-03202024_060312.xml","form_type":"4"}},{"id":1566169,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-20T18:00:25.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":613,"price":26.4022,"value":16184.5486,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.25 to $26.75, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-24-008771","document":"form4-03202024_060312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924008771/form4-03202024_060312.xml","form_type":"4"}},{"id":1566168,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-20T18:00:25.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":6387,"price":25.8137,"value":164872.1019,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.25 to $26.18, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3864,"source":{"system":"sec-edgar","filing":"0001415889-24-008771","document":"form4-03202024_060312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924008771/form4-03202024_060312.xml","form_type":"4"}},{"id":1566167,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-20T18:00:25.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":2.14,"value":6420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":10251,"source":{"system":"sec-edgar","filing":"0001415889-24-008771","document":"form4-03202024_060312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924008771/form4-03202024_060312.xml","form_type":"4"}},{"id":1566166,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-20T18:00:25.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":1.74,"value":6960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":7251,"source":{"system":"sec-edgar","filing":"0001415889-24-008771","document":"form4-03202024_060312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924008771/form4-03202024_060312.xml","form_type":"4"}},{"id":1584470,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-11T18:00:15.000Z","date":"2024-03-07","kind":"exercise","planned":true,"acquired":false,"shares":8030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 109,640 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":101510,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":8030},"source":{"system":"sec-edgar","filing":"0001415889-24-007533","document":"form4-03112024_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924007533/form4-03112024_060304.xml","form_type":"4"}},{"id":1584469,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-11T18:00:15.000Z","date":"2024-03-07","kind":"exercise","planned":true,"acquired":false,"shares":945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":15324,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":945},"source":{"system":"sec-edgar","filing":"0001415889-24-007533","document":"form4-03112024_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924007533/form4-03112024_060304.xml","form_type":"4"}},{"id":1584468,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-11T18:00:15.000Z","date":"2024-03-07","kind":"sale","planned":true,"acquired":false,"shares":8975,"price":24.5,"value":219887.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-24-007533","document":"form4-03112024_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924007533/form4-03112024_060304.xml","form_type":"4"}},{"id":1584467,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-11T18:00:15.000Z","date":"2024-03-07","kind":"exercise","planned":true,"acquired":true,"shares":8975,"price":2.14,"value":19206.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":12226,"source":{"system":"sec-edgar","filing":"0001415889-24-007533","document":"form4-03112024_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924007533/form4-03112024_060304.xml","form_type":"4"}},{"id":1616203,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-27T18:00:07.000Z","date":"2024-02-23","kind":"exercise","planned":true,"acquired":false,"shares":511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":3014,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":511},"source":{"system":"sec-edgar","filing":"0001415889-24-005571","document":"form4-02272024_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924005571/form4-02272024_060201.xml","form_type":"4"}},{"id":1616202,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T18:00:07.000Z","date":"2024-02-23","kind":"sale","planned":true,"acquired":false,"shares":511,"price":19.5,"value":9964.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-24-005571","document":"form4-02272024_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924005571/form4-02272024_060201.xml","form_type":"4"}},{"id":1616201,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T18:00:07.000Z","date":"2024-02-23","kind":"exercise","planned":true,"acquired":true,"shares":511,"price":1.74,"value":889.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3762,"source":{"system":"sec-edgar","filing":"0001415889-24-005571","document":"form4-02272024_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924005571/form4-02272024_060201.xml","form_type":"4"}},{"id":1625674,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T18:00:22.000Z","date":"2024-02-20","kind":"exercise","planned":true,"acquired":false,"shares":987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":8036,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":987},"source":{"system":"sec-edgar","filing":"0001415889-24-004903","document":"form4-02222024_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924004903/form4-02222024_060201.xml","form_type":"4"}},{"id":1625673,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T18:00:22.000Z","date":"2024-02-20","kind":"exercise","planned":true,"acquired":false,"shares":2502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":3525,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":2502},"source":{"system":"sec-edgar","filing":"0001415889-24-004903","document":"form4-02222024_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924004903/form4-02222024_060201.xml","form_type":"4"}},{"id":1625672,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-22T18:00:22.000Z","date":"2024-02-20","kind":"sale","planned":true,"acquired":false,"shares":898,"price":20.5766,"value":18477.7868,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.55 to $20.67, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-24-004903","document":"form4-02222024_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924004903/form4-02222024_060201.xml","form_type":"4"}},{"id":1625671,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-22T18:00:22.000Z","date":"2024-02-20","kind":"sale","planned":true,"acquired":false,"shares":2591,"price":20.1068,"value":52096.7188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.53 to $20.515, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":4149,"source":{"system":"sec-edgar","filing":"0001415889-24-004903","document":"form4-02222024_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924004903/form4-02222024_060201.xml","form_type":"4"}},{"id":1625670,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-22T18:00:22.000Z","date":"2024-02-20","kind":"exercise","planned":true,"acquired":true,"shares":3489,"price":1.74,"value":6070.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":6740,"source":{"system":"sec-edgar","filing":"0001415889-24-004903","document":"form4-02222024_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924004903/form4-02222024_060201.xml","form_type":"4"}},{"id":1672205,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-24T18:00:24.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":66586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024."}],"balance_after":66586,"derivative":{"exercise_price":20,"expiration_date":"2034-01-21","underlying":"Common Stock","underlying_shares":66586},"source":{"system":"sec-edgar","filing":"0001415889-24-001774","document":"form4-01242024_060106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924001774/form4-01242024_060106.xml","form_type":"4"}},{"id":1675400,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T18:00:08.000Z","date":"2024-01-17","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":6027,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001415889-24-001609","document":"form4-01192024_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924001609/form4-01192024_060101.xml","form_type":"4"}},{"id":1675399,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-01-19T18:00:08.000Z","date":"2024-01-17","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":19.5,"value":78000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-24-001609","document":"form4-01192024_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924001609/form4-01192024_060101.xml","form_type":"4"}},{"id":1675398,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-01-19T18:00:08.000Z","date":"2024-01-17","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":1.74,"value":6960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":7251,"source":{"system":"sec-edgar","filing":"0001415889-24-001609","document":"form4-01192024_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588924001609/form4-01192024_060101.xml","form_type":"4"}},{"id":1698065,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-29T18:00:07.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 109,640 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":109540,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001415889-23-017025","document":"form4-12292023_061202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923017025/form4-12292023_061202.xml","form_type":"4"}},{"id":1698064,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-29T18:00:07.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":false,"shares":25,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":16269,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":25},"source":{"system":"sec-edgar","filing":"0001415889-23-017025","document":"form4-12292023_061202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923017025/form4-12292023_061202.xml","form_type":"4"}},{"id":1698063,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-12-29T18:00:07.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":125,"price":24.5,"value":3062.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-23-017025","document":"form4-12292023_061202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923017025/form4-12292023_061202.xml","form_type":"4"}},{"id":1698062,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-12-29T18:00:07.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":true,"shares":125,"price":2.14,"value":267.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3376,"source":{"system":"sec-edgar","filing":"0001415889-23-017025","document":"form4-12292023_061202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923017025/form4-12292023_061202.xml","form_type":"4"}},{"id":1701076,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-22T18:00:13.000Z","date":"2023-12-20","kind":"exercise","planned":true,"acquired":false,"shares":1076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":10027,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1076},"source":{"system":"sec-edgar","filing":"0001415889-23-016908","document":"form4-12222023_061202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016908/form4-12222023_061202.xml","form_type":"4"}},{"id":1701075,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-22T18:00:13.000Z","date":"2023-12-20","kind":"exercise","planned":true,"acquired":false,"shares":2924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":9023,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":2924},"source":{"system":"sec-edgar","filing":"0001415889-23-016908","document":"form4-12222023_061202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016908/form4-12222023_061202.xml","form_type":"4"}},{"id":1701074,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-12-22T18:00:13.000Z","date":"2023-12-20","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":19.5,"value":78000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-23-016908","document":"form4-12222023_061202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016908/form4-12222023_061202.xml","form_type":"4"}},{"id":1701073,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-12-22T18:00:13.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":1.74,"value":6960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":7251,"source":{"system":"sec-edgar","filing":"0001415889-23-016908","document":"form4-12222023_061202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016908/form4-12222023_061202.xml","form_type":"4"}},{"id":1709514,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T18:00:07.000Z","date":"2023-12-14","kind":"exercise","planned":true,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":10306,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":7197},"source":{"system":"sec-edgar","filing":"0001415889-23-016539","document":"form4-12152023_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016539/form4-12152023_061201.xml","form_type":"4"}},{"id":1709513,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T18:00:07.000Z","date":"2023-12-14","kind":"exercise","planned":true,"acquired":false,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":12744,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0001415889-23-016539","document":"form4-12152023_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016539/form4-12152023_061201.xml","form_type":"4"}},{"id":1709512,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T18:00:07.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":false,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":17503,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1450},"source":{"system":"sec-edgar","filing":"0001415889-23-016539","document":"form4-12152023_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016539/form4-12152023_061201.xml","form_type":"4"}},{"id":1709511,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T18:00:07.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":false,"shares":653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":15444,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":653},"source":{"system":"sec-edgar","filing":"0001415889-23-016539","document":"form4-12152023_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016539/form4-12152023_061201.xml","form_type":"4"}},{"id":1709510,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-12-15T18:00:07.000Z","date":"2023-12-14","kind":"sale","planned":true,"acquired":false,"shares":9897,"price":19.5,"value":192991.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-23-016539","document":"form4-12152023_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016539/form4-12152023_061201.xml","form_type":"4"}},{"id":1709509,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-12-15T18:00:07.000Z","date":"2023-12-14","kind":"exercise","planned":true,"acquired":true,"shares":9897,"price":1.74,"value":17220.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":13148,"source":{"system":"sec-edgar","filing":"0001415889-23-016539","document":"form4-12152023_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016539/form4-12152023_061201.xml","form_type":"4"}},{"id":1709508,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-12-15T18:00:07.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":2103,"price":19.5,"value":41008.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-23-016539","document":"form4-12152023_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016539/form4-12152023_061201.xml","form_type":"4"}},{"id":1709507,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-12-15T18:00:07.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":true,"shares":2103,"price":1.74,"value":3659.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":5354,"source":{"system":"sec-edgar","filing":"0001415889-23-016539","document":"form4-12152023_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923016539/form4-12152023_061201.xml","form_type":"4"}},{"id":1881316,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-23T18:00:10.000Z","date":"2023-05-19","kind":"exercise","planned":true,"acquired":false,"shares":65,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":18953,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":65},"source":{"system":"sec-edgar","filing":"0001415889-23-008658","document":"form4-05232023_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923008658/form4-05232023_060501.xml","form_type":"4"}},{"id":1881315,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-05-23T18:00:10.000Z","date":"2023-05-19","kind":"sale","planned":true,"acquired":false,"shares":65,"price":19.5,"value":1267.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-23-008658","document":"form4-05232023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923008658/form4-05232023_060501.xml","form_type":"4"}},{"id":1881314,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-05-23T18:00:10.000Z","date":"2023-05-19","kind":"exercise","planned":true,"acquired":true,"shares":65,"price":1.74,"value":113.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":3316,"source":{"system":"sec-edgar","filing":"0001415889-23-008658","document":"form4-05232023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923008658/form4-05232023_060501.xml","form_type":"4"}},{"id":1884919,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-19T18:00:25.000Z","date":"2023-05-17","kind":"exercise","planned":true,"acquired":false,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":19018,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1090},"source":{"system":"sec-edgar","filing":"0001415889-23-008425","document":"form4-05192023_060504.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923008425/form4-05192023_060504.xml","form_type":"4"}},{"id":1884918,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-05-19T18:00:25.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":1090,"price":19.5925,"value":21355.825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.50 to $19.665, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001415889-23-008425","document":"form4-05192023_060504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923008425/form4-05192023_060504.xml","form_type":"4"}},{"id":1884917,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-05-19T18:00:25.000Z","date":"2023-05-17","kind":"exercise","planned":true,"acquired":true,"shares":1090,"price":1.74,"value":1896.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,291 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b3(d)."}],"balance_after":4341,"source":{"system":"sec-edgar","filing":"0001415889-23-008425","document":"form4-05192023_060504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923008425/form4-05192023_060504.xml","form_type":"4"}},{"id":1914292,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-25T18:00:08.000Z","date":"2023-04-21","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":20108,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001415889-23-006838","document":"form4-04252023_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923006838/form4-04252023_060401.xml","form_type":"4"}},{"id":1914291,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-04-25T18:00:08.000Z","date":"2023-04-21","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":19.5,"value":78000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-23-006838","document":"form4-04252023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923006838/form4-04252023_060401.xml","form_type":"4"}},{"id":1914290,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-04-25T18:00:08.000Z","date":"2023-04-21","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":1.74,"value":6960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023."}],"balance_after":5960,"source":{"system":"sec-edgar","filing":"0001415889-23-006838","document":"form4-04252023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923006838/form4-04252023_060401.xml","form_type":"4"}},{"id":2026681,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T18:10:12.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on March 7, 2023."}],"balance_after":62000,"derivative":{"exercise_price":25.57,"expiration_date":"2033-02-06","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001415889-23-002172","document":"form4-02082023_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000141588923002172/form4-02082023_060201.xml","form_type":"4"}},{"id":2470143,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-16T18:00:17.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":65433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on January 14, 2022."}],"balance_after":65433,"derivative":{"exercise_price":10.61,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":65433},"source":{"system":"sec-edgar","filing":"0001493152-21-031753","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000149315221031753/ownership.xml","form_type":"4"}},{"id":2648095,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T18:31:27.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":60300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on June 29, 2022."}],"balance_after":60300,"derivative":{"exercise_price":14,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":60300},"source":{"system":"sec-edgar","filing":"0001104659-21-088378","document":"tm2121189-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000110465921088378/tm2121189-3_4seq1.xml","form_type":"4"}},{"id":2648094,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T18:31:27.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":109640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on July 4, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":109640,"derivative":{"exercise_price":2.144,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":109640},"source":{"system":"sec-edgar","filing":"0001104659-21-088378","document":"tm2121189-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000110465921088378/tm2121189-3_4seq1.xml","form_type":"4"}},{"id":2648093,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89882,"kind":"person","name":"Gillies Hunter","position":1,"cik":"0001868997","reported_name":"Gillies Hunter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T18:31:27.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":16294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vested on May 2, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":16294,"derivative":{"exercise_price":2.144,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":16294},"source":{"system":"sec-edgar","filing":"0001104659-21-088378","document":"tm2121189-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868997/000110465921088378/tm2121189-3_4seq1.xml","form_type":"4"}}]}